Muscle Relaxation Therapy With Odorant Cue

N/ACompletedNCT00208910

Emory University15 enrolled

Overview

A novel procedure for generalized anxiety disorder where an odorant cue is paired with the state of deep relaxation during training. It is hypothesized that by smelling the odor in an anxiety-provoking situation, the patient will more easily invoke a state of relaxation, providing greater relief from the distressing tension and worry that characterize GAD.

We hypothesize that by presenting a novel odor to a patient in a state of deep relaxation, the odor will serve as a conditioned inhibitory stimulus, or safety signal, in anxiety-provoking situations. With the odor serving as a contextual cue for the state of relaxation.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Generalized Anxiety Disorder Anxiety

Interventions

Odorant CueBEHAVIORAL

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * GAD without a comorbid active major psychiatric disorder. * GAD must be the primary active psychiatric disorder. * GAD determined via the Mini International Neuropsychiatric Interview (MINI). Exclusion Criteria: * Significant medical illness that might interfere with the relaxation therapy or with training using the odorant. * Actively abusing alcohol. * Illicit substances. * Currently using rapid-acting anxiolytic agents (e.g. benzodiazepines, hydroxyzine). * Started an antidepressant, antipsychotic or mood stabilizing agent within three months of screening visit.

Locations (1)

Emory University School of Medicine

Atlanta, Georgia, United States

Outcomes

Primary Outcomes

PSWQ

Secondary Outcomes

HAM-A

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.